• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4658978)   Today's Articles (4162)   Subscriber (51294)
For: Yahav D, Giske CG, Grāmatniece A, Abodakpi H, Tam VH, Leibovici L. New β-Lactam-β-Lactamase Inhibitor Combinations. Clin Microbiol Rev 2020;34:e00115-20. [PMID: 33177185 PMCID: PMC7667665 DOI: 10.1128/cmr.00115-20] [Citation(s) in RCA: 280] [Impact Index Per Article: 70.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]  Open
Number Cited by Other Article(s)
1
Polani R, De Francesco A, Tomolillo D, Artuso I, Equestre M, Trirocco R, Arcari G, Antonelli G, Villa L, Prosseda G, Visca P, Carattoli A. Cefiderocol Resistance Conferred by Plasmid-Located Ferric Citrate Transport System in KPC-Producing Klebsiella pneumoniae. Emerg Infect Dis 2025;31:123-124. [PMID: 39714320 DOI: 10.3201/eid3101.241426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2024]  Open
2
Bianco G, Boattini M, Lupo L, Ambretti S, Greco R, Degl'Innocenti L, Chiatamone Ranieri S, Fasciana T, Mazzariol A, Gibellini D, Antonelli G, Sacco F, Quirino A, Farina C, Paglietti B, Comini S, Fiamma M, Broccolo F, Cavallo R, Costa C, Gaibani P. In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022-23). J Antimicrob Chemother 2024:dkae450. [PMID: 39699187 DOI: 10.1093/jac/dkae450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Accepted: 11/28/2024] [Indexed: 12/20/2024]  Open
3
Zhou P, Gao H, Li M, Wu C, Han W, Wan C, Shen L, Yuan X, Shi J, Huang Y, Lv J, Zhou Y, Yu F. Characterization of a Novel KPC-2 Variant, KPC-228, Conferring Resistance to Ceftazidime-Avibactam in an ST11-KL64 Hypervirulent Klebsiella pneumoniae. Int J Antimicrob Agents 2024:107411. [PMID: 39709132 DOI: 10.1016/j.ijantimicag.2024.107411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2024] [Revised: 12/06/2024] [Accepted: 12/10/2024] [Indexed: 12/23/2024]
4
Gil-Gil T, Laborda P, Martínez JL, Hernando-Amado S. Use of adjuvants to improve antibiotic efficacy and reduce the burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2024. [PMID: 39670956 DOI: 10.1080/14787210.2024.2441891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2024] [Revised: 10/28/2024] [Accepted: 12/10/2024] [Indexed: 12/14/2024]
5
Veeraraghavan B, Walia K, Egli A. Re: 'Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates' by Poirel et al. Clin Microbiol Infect 2024:S1198-743X(24)00596-2. [PMID: 39672465 DOI: 10.1016/j.cmi.2024.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2024] [Accepted: 12/07/2024] [Indexed: 12/15/2024]
6
Liu X, Li Z, Zhang F, Yang X, Lei Z, Li C, Wu Y, Zhao J, Zhang Y, Hu Y, Shen F, Wang P, Yang J, Liu Y, Shi H, Lu B. In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China. Int J Antimicrob Agents 2024:107407. [PMID: 39672348 DOI: 10.1016/j.ijantimicag.2024.107407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Revised: 11/30/2024] [Accepted: 12/05/2024] [Indexed: 12/15/2024]
7
Richards GA, Perovic O, Brink AJ. The challenges of difficult-to-treat Acinetobacter infections. Clin Microbiol Rev 2024;37:e0009324. [PMID: 39555919 PMCID: PMC11629631 DOI: 10.1128/cmr.00093-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2024]  Open
8
Wang X, Lu Z, Dou L, Ma L, He T, Gao C, Zhao X, Tao J, Luo L, Li Q, Wang Y, Shen Y, Shen J, Wang Z, Wen K. Modified Carba PBP test for rapid detection and differentiation between different classes of carbapenemases in Enterobacterales. Mikrochim Acta 2024;192:7. [PMID: 39636434 DOI: 10.1007/s00604-024-06859-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2024] [Accepted: 11/23/2024] [Indexed: 12/07/2024]
9
Luo Q, Lu P, Chen Y, Shen P, Zheng B, Ji J, Ying C, Liu Z, Xiao Y. ESKAPE in China: epidemiology and characteristics of antibiotic resistance. Emerg Microbes Infect 2024;13:2317915. [PMID: 38356197 PMCID: PMC10896150 DOI: 10.1080/22221751.2024.2317915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Accepted: 02/08/2024] [Indexed: 02/16/2024]
10
Hidalgo-Tenorio C, Bou G, Oliver A, Rodríguez-Aguirregabiria M, Salavert M, Martínez-Martínez L. The Challenge of Treating Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review. Drugs 2024;84:1519-1539. [PMID: 39467989 DOI: 10.1007/s40265-024-02102-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/19/2024] [Indexed: 10/30/2024]
11
Bouvier M, Bachtarzi M, Poirel L, Nordmann P. Rapid detection of imipenem/relebactam susceptibility/resistance in Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 2024;110:116474. [PMID: 39191152 DOI: 10.1016/j.diagmicrobio.2024.116474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2024] [Revised: 07/10/2024] [Accepted: 07/29/2024] [Indexed: 08/29/2024]
12
Bassetti M, Vena A, Larosa B, Giacobbe DR. New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria. Curr Opin Infect Dis 2024;37:582-588. [PMID: 39106036 PMCID: PMC11556884 DOI: 10.1097/qco.0000000000001056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/07/2024]
13
Gundeslioglu OO, Haytoglu Z, Gumus HH, Ekinci F, Kibar F, Cay U, Alabaz D, Ozlu F, Horoz OO, Yıldızdas RD. Clinical experience with ceftazidime/avibactam for the treatment of extensively drug-resistant or pandrug-resistant Klebsiella pneumoniae in neonates and children. Eur J Clin Microbiol Infect Dis 2024;43:2361-2369. [PMID: 39352616 DOI: 10.1007/s10096-024-04948-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Accepted: 09/17/2024] [Indexed: 12/01/2024]
14
Al Musawa M, Bleick CR, Herbin SR, Caniff KE, Van Helden SR, Rybak MJ. Aztreonam-avibactam: The dynamic duo against multidrug-resistant gram-negative pathogens. Pharmacotherapy 2024. [PMID: 39601336 DOI: 10.1002/phar.4629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2024] [Revised: 11/01/2024] [Accepted: 11/04/2024] [Indexed: 11/29/2024]
15
Le Terrier C, Raro OHF, Saad AM, Nordmann P, Poirel L. In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates. Eur J Clin Microbiol Infect Dis 2024:10.1007/s10096-024-04965-x. [PMID: 39589655 DOI: 10.1007/s10096-024-04965-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Accepted: 10/09/2024] [Indexed: 11/27/2024]
16
Jung J, Park H, Oh S, Choi J, An S, Jeong Y, Kim J, Baek YJ, Lee E, Kim TH. Impact of universal contact precautions and chlorhexidine bathing on the acquisition of carbapenem-resistant enterobacterales in the intensive care unit: a cohort study. Antimicrob Resist Infect Control 2024;13:139. [PMID: 39578838 PMCID: PMC11583449 DOI: 10.1186/s13756-024-01495-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2024] [Accepted: 11/16/2024] [Indexed: 11/24/2024]  Open
17
Lee JA, Kuo YW, Du SH, Lee TF, Liao CH, Huang YT, Hsueh PR. High diversity of strain clonality and metallo-β-lactamases genes among carbapenem-resistant Enterobacterales in Taiwan. Eur J Clin Microbiol Infect Dis 2024:10.1007/s10096-024-04993-7. [PMID: 39551908 DOI: 10.1007/s10096-024-04993-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2024] [Accepted: 11/11/2024] [Indexed: 11/19/2024]
18
Yang W, Xu H, Zhao Y, Chen W, Ma X, Hu F. Identification of blaKPC-90 in Klebsiella pneumoniae associated with ceftazidime-avibactam resistance and the translocation & truncation of resistant genes mediated by IS26. Int J Antimicrob Agents 2024;65:107388. [PMID: 39551275 DOI: 10.1016/j.ijantimicag.2024.107388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2024] [Revised: 10/06/2024] [Accepted: 11/11/2024] [Indexed: 11/19/2024]
19
Sangiorgio G, Calvo M, Stefani S. Aztreonam and avibactam combination therapy for metallo-β-lactamase-producing gram-negative bacteria: a comprehensive review. Clin Microbiol Infect 2024:S1198-743X(24)00532-9. [PMID: 39528085 DOI: 10.1016/j.cmi.2024.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2024] [Revised: 10/28/2024] [Accepted: 11/05/2024] [Indexed: 11/16/2024]
20
Cai H, Chen M, Li Y, Wang N, Ni H, Zhang P, Hua X, Yu Y. In vivo divergent evolution of cross-resistance to new β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime/avibactam treatment. Infection 2024:10.1007/s15010-024-02432-5. [PMID: 39514175 DOI: 10.1007/s15010-024-02432-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Accepted: 10/30/2024] [Indexed: 11/16/2024]
21
Forstner P, Fuchs L, Luxner J, Grisold A, Steinmetz I, Dichtl K. Colistin, Meropenem-Vaborbactam, Imipenem-Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2. Antibiotics (Basel) 2024;13:1062. [PMID: 39596756 PMCID: PMC11591322 DOI: 10.3390/antibiotics13111062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2024] [Revised: 10/29/2024] [Accepted: 11/06/2024] [Indexed: 11/29/2024]  Open
22
Herrera C, Gomis-Font MA, López-Causapé C, Díez-Aguilar M, Fraile-Ribot PA, Cardeñoso LM, Oliver A. Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections. Antimicrob Agents Chemother 2024;68:e0116424. [PMID: 39431817 PMCID: PMC11539206 DOI: 10.1128/aac.01164-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Accepted: 09/23/2024] [Indexed: 10/22/2024]  Open
23
Le Terrier C, Mlynarcik P, Sadek M, Nordmann P, Poirel L. Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamases. Antimicrob Agents Chemother 2024;68:e0077524. [PMID: 39365068 PMCID: PMC11539244 DOI: 10.1128/aac.00775-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2024] [Accepted: 09/11/2024] [Indexed: 10/05/2024]  Open
24
Werner J, Umstätter F, Böhmann MB, Müller H, Beijer B, Hertlein T, Kaschnitz L, Bram V, Kleist C, Klika KD, Mühlberg E, Braune G, Wohlfart S, Gärtner M, Peter S, Zimmermann S, Haberkorn U, Ohlsen K, Brötz-Oesterhelt H, Mier W, Uhl P. Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β-Lactam Antibiotics. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2024:e2411406. [PMID: 39499737 DOI: 10.1002/advs.202411406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Revised: 10/28/2024] [Indexed: 11/07/2024]
25
Bassetti M, Larosa B, Vena A, Giacobbe DR. Novel agents in development for the treatment of resistant Gram-negative infections. Expert Rev Anti Infect Ther 2024;22:965-976. [PMID: 39292619 DOI: 10.1080/14787210.2024.2407068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2024] [Revised: 08/28/2024] [Accepted: 09/17/2024] [Indexed: 09/20/2024]
26
O'Jeanson A, Nielsen EI, Friberg LE. Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study. J Antimicrob Chemother 2024:dkae375. [PMID: 39436757 DOI: 10.1093/jac/dkae375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2024] [Accepted: 10/04/2024] [Indexed: 10/25/2024]  Open
27
Lawrence J, O'Hare D, van Batenburg-Sherwood J, Sutton M, Holmes A, Rawson TM. Innovative approaches in phenotypic beta-lactamase detection for personalised infection management. Nat Commun 2024;15:9070. [PMID: 39433753 PMCID: PMC11494114 DOI: 10.1038/s41467-024-53192-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2024] [Accepted: 10/04/2024] [Indexed: 10/23/2024]  Open
28
Albac S, Anzala N, Bonnot D, Djama C, Chavanet P, Croisier D. Development of a new Acinetobacter baumannii pneumonia rabbit model for the preclinical evaluation of future anti-infective strategies. Microbiol Spectr 2024;12:e0157024. [PMID: 39422502 PMCID: PMC11619384 DOI: 10.1128/spectrum.01570-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Accepted: 08/01/2024] [Indexed: 10/19/2024]  Open
29
Carmeli Y, Cisneros JM, Paul M, Daikos GL, Wang M, Torre-Cisneros J, Singer G, Titov I, Gumenchuk I, Zhao Y, Jiménez-Rodríguez RM, Liang L, Chen G, Pyptiuk O, Aksoy F, Rogers H, Wible M, Arhin FF, Luckey A, Leaney JL, Pypstra R, Chow JW. Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial. THE LANCET. INFECTIOUS DISEASES 2024:S1473-3099(24)00499-7. [PMID: 39389071 DOI: 10.1016/s1473-3099(24)00499-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2024] [Revised: 07/22/2024] [Accepted: 07/25/2024] [Indexed: 10/12/2024]
30
Medrano FJ, Hernando-Amado S, Martínez JL, Romero A. A new type of Class C β-lactamases defined by PIB-1. A metal-dependent carbapenem-hydrolyzing β-lactamase, from Pseudomonas aeruginosa: Structural and functional analysis. Int J Biol Macromol 2024;277:134298. [PMID: 39097051 DOI: 10.1016/j.ijbiomac.2024.134298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Revised: 07/18/2024] [Accepted: 07/28/2024] [Indexed: 08/05/2024]
31
Li W, Tao Z, Zhou M, Jiang H, Wang L, Ji B, Zhao Y. Antibiotic adjuvants against multidrug-resistant Gram-negative bacteria: important component of future antimicrobial therapy. Microbiol Res 2024;287:127842. [PMID: 39032266 DOI: 10.1016/j.micres.2024.127842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2024] [Revised: 07/13/2024] [Accepted: 07/14/2024] [Indexed: 07/23/2024]
32
Wang J, Mu M, Zhu J, Yang J, Tao Y, Chen Y, Hu Q, Zhou H, Zhao A, Niu T. Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria. Ann Hematol 2024;103:4021-4031. [PMID: 38958702 PMCID: PMC11512823 DOI: 10.1007/s00277-024-05866-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Accepted: 06/24/2024] [Indexed: 07/04/2024]
33
Mehta D, Singh S. Nanozymes and their biomolecular conjugates as next-generation antibacterial agents: A comprehensive review. Int J Biol Macromol 2024;278:134582. [PMID: 39122068 DOI: 10.1016/j.ijbiomac.2024.134582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2024] [Revised: 07/27/2024] [Accepted: 08/06/2024] [Indexed: 08/12/2024]
34
Fan P, Fu P, Liu J, Wang C, Zhang X, Wang Y, Zhang Y, Zhu T, Zhang C, Lu G, Yan G. Monitoring of Klebsiella pneumoniae Infection and Drug Resistance in 17 Pediatric Intensive Care Units in China from 2016 to 2022. Infect Drug Resist 2024;17:4125-4136. [PMID: 39351447 PMCID: PMC11440422 DOI: 10.2147/idr.s475720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2024] [Accepted: 08/26/2024] [Indexed: 10/04/2024]  Open
35
Tebano G, Zaghi I, Cricca M, Cristini F. Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales. PHARMACY 2024;12:142. [PMID: 39311133 PMCID: PMC11417830 DOI: 10.3390/pharmacy12050142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2024] [Revised: 09/14/2024] [Accepted: 09/18/2024] [Indexed: 09/26/2024]  Open
36
Jacobs MR, Abdelhamed AM, Good CE, Mack AR, Bethel CR, Marshall S, Hujer AM, Hujer KM, Patel R, van Duin D, Fowler VG, Rhoads DD, Six DA, Moeck G, Uehara T, Papp-Wallace KM, Bonomo RA. ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime. Antimicrob Agents Chemother 2024;68:e0075124. [PMID: 39133021 PMCID: PMC11373228 DOI: 10.1128/aac.00751-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Accepted: 07/14/2024] [Indexed: 08/13/2024]  Open
37
Fu Y, Zhu Y, Zhao F, Yao B, Yu Y, Zhang J, Chen Q. In vitro Synergistic and Bactericidal Effects of Aztreonam in Combination with Ceftazidime/ Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam Against Dual-Carbapenemase-Producing Enterobacterales. Infect Drug Resist 2024;17:3851-3861. [PMID: 39247757 PMCID: PMC11380864 DOI: 10.2147/idr.s474150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Accepted: 08/27/2024] [Indexed: 09/10/2024]  Open
38
Gao N, Zhou J, Li G, Liu R, Lu G, Shen J. Methodological Evaluation of Carbapenemase Detection by Different Methods. Pol J Microbiol 2024;73:383-394. [PMID: 39268952 PMCID: PMC11395418 DOI: 10.33073/pjm-2024-034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2024] [Accepted: 07/31/2024] [Indexed: 09/15/2024]  Open
39
Pfennigwerth N, Gatermann S. [Importance and prevalence of multidrug-resistant gram-negative bacteria in Germany]. Dtsch Med Wochenschr 2024;149:1143-1150. [PMID: 39250952 DOI: 10.1055/a-2283-6807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/11/2024]
40
Dos Anjos C, Wang Y, Truong-Bolduc QC, Bolduc PK, Liu M, Hooper DC, Anderson RR, Dai T, Leanse LG. Blue Light Compromises Bacterial β-Lactamases Activity to Overcome β-Lactam Resistance. Lasers Surg Med 2024;56:673-681. [PMID: 39039622 DOI: 10.1002/lsm.23819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Revised: 05/03/2024] [Accepted: 06/10/2024] [Indexed: 07/24/2024]
41
Morecchiato F, Coppi M, Chilleri C, Antonelli A, Giani T, Rossolini GM. Evaluation of Quantamatrix dRASTTM system for rapid antimicrobial susceptibility testing of bacterial isolates from positive blood cultures, in comparison with commercial Micronaut broth microdilution system. Diagn Microbiol Infect Dis 2024;110:116436. [PMID: 39003931 DOI: 10.1016/j.diagmicrobio.2024.116436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Revised: 07/10/2024] [Accepted: 07/10/2024] [Indexed: 07/16/2024]
42
Tellapragada C, Razavi M, Peris PS, Jonsson P, Vondracek M, Giske CG. Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability. Int J Antimicrob Agents 2024;64:107256. [PMID: 38925228 DOI: 10.1016/j.ijantimicag.2024.107256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Revised: 05/21/2024] [Accepted: 06/17/2024] [Indexed: 06/28/2024]
43
Wilhelm CM, Antochevis LC, Magagnin CM, Arns B, Vieceli T, Pereira DC, Lutz L, de Souza ÂC, Dos Santos JN, Guerra RR, Medeiros GS, Santoro L, Falci DR, Rigatto MH, Barth AL, Martins AF, Zavascki AP. Susceptibility evaluation of novel beta-lactam/beta-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in hospitalized patients in Brazil. J Glob Antimicrob Resist 2024;38:247-251. [PMID: 38936472 DOI: 10.1016/j.jgar.2024.06.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 05/13/2024] [Accepted: 06/07/2024] [Indexed: 06/29/2024]  Open
44
Dulanto Chiang A, Dekker JP. Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria. COMMUNICATIONS MEDICINE 2024;4:170. [PMID: 39210044 PMCID: PMC11362173 DOI: 10.1038/s43856-024-00591-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Accepted: 08/14/2024] [Indexed: 09/04/2024]  Open
45
Alfei S, Zuccari G, Bacchetti F, Torazza C, Milanese M, Siciliano C, Athanassopoulos CM, Piatti G, Schito AM. Synthesized Bis-Triphenyl Phosphonium-Based Nano Vesicles Have Potent and Selective Antibacterial Effects on Several Clinically Relevant Superbugs. NANOMATERIALS (BASEL, SWITZERLAND) 2024;14:1351. [PMID: 39195389 DOI: 10.3390/nano14161351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/10/2024] [Revised: 08/05/2024] [Accepted: 08/13/2024] [Indexed: 08/29/2024]
46
Lewis RE, Palombo M, Diani E, Secci B, Gibellini D, Gaibani P. Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria. Cells 2024;13:1315. [PMID: 39195205 DOI: 10.3390/cells13161315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2024] [Revised: 07/31/2024] [Accepted: 08/02/2024] [Indexed: 08/29/2024]  Open
47
Gao W, Liu X, Zhang S, Wang J, Qiu B, Shao J, Huang W, Huang Y, Yao M, Tang LL. Alterations in gut microbiota and inflammatory cytokines after administration of antibiotics in mice. Microbiol Spectr 2024;12:e0309523. [PMID: 38899904 PMCID: PMC11302321 DOI: 10.1128/spectrum.03095-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Accepted: 03/13/2024] [Indexed: 06/21/2024]  Open
48
Niu W, Ti R, Li D, Dong R, Dong J, Ye Y, Xiao Y, Wang Z. Structural insight into the subclass B1 metallo-β-lactamase AFM-1. Biochem Biophys Res Commun 2024;720:150102. [PMID: 38759302 DOI: 10.1016/j.bbrc.2024.150102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2024] [Revised: 04/29/2024] [Accepted: 05/10/2024] [Indexed: 05/19/2024]
49
Sendra E, Fernández-Muñoz A, Zamorano L, Oliver A, Horcajada JP, Juan C, Gómez-Zorrilla S. Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective. Infection 2024;52:1235-1268. [PMID: 38954392 PMCID: PMC11289218 DOI: 10.1007/s15010-024-02313-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2024] [Accepted: 05/30/2024] [Indexed: 07/04/2024]
50
Raro OHF, Bouvier M, Kerbol A, Poirel L, Nordmann P. MultiRapid ATB NP test for detecting concomitant susceptibility and resistance of last-resort novel antibiotics available to treat multidrug-resistant Enterobacterales infections. Int J Antimicrob Agents 2024;64:107206. [PMID: 38754526 DOI: 10.1016/j.ijantimicag.2024.107206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2024] [Revised: 04/23/2024] [Accepted: 05/09/2024] [Indexed: 05/18/2024]
PrevPage 1 of 6 123456Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA